World-first clinical trials of a groundbreaking treatment for aggressive brain tumours are likely to begin soon following “fantastic" results in the high-profile case of Australian of the Year, Professor Richard Scolyer.
Melanoma News
Men With Melanoma Who Receive Enhanced Vaccine Experience Improvements in Overall Survival
It is unclear why the vaccines were less effective in women, but researchers note that the findings can be important when determining immune therapy outcomes in patients with melanoma.
Meta-Analysis: Rate of Malignancy Low in Pediatric Longitudinal Melanonychia
Despite a high frequency of atypical features, longitudinal melanonychia (LM) in children is associated with an exceedingly low rate of malignancy.
Melanoma Survivors Should ‘Talk Through’ Fear of Recurrence
Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.